GLABF
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Sep 22 closing price
Capitalization
27.77M
VKTX
Price
$24.97
Change
-$1.28 (-4.88%)
Updated
Sep 23 closing price
Capitalization
2.81B
28 days until earnings call
Interact to see
Advertisement

GLABF vs VKTX

Header iconGLABF vs VKTX Comparison
Open Charts GLABF vs VKTXBanner chart's image
GEMINA LABORATORIES
Price$0.41
Change-$0.00 (-0.00%)
Volume$1K
Capitalization27.77M
Viking Therapeutics
Price$24.97
Change-$1.28 (-4.88%)
Volume$4.69M
Capitalization2.81B
GLABF vs VKTX Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. VKTX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Buy and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GLABF: $0.41 vs. VKTX: $24.97)
Brand notoriety: GLABF and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 9% vs. VKTX: 66%
Market capitalization -- GLABF: $27.77M vs. VKTX: $2.81B
GLABF [@Biotechnology] is valued at $27.77M. VKTX’s [@Biotechnology] market capitalization is $2.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 2 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • GLABF’s TA Score: 2 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than GLABF.

Price Growth

GLABF (@Biotechnology) experienced а +64.00% price change this week, while VKTX (@Biotechnology) price change was +5.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.81B) has a higher market cap than GLABF($27.8M). GLABF YTD gains are higher at: -24.936 vs. VKTX (-37.947). GLABF has higher annual earnings (EBITDA): -3.73M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. GLABF (15K). GLABF has less debt than VKTX: GLABF (244K) vs VKTX (878K). GLABF has higher revenues than VKTX: GLABF (10.9K) vs VKTX (0).
GLABFVKTXGLABF / VKTX
Capitalization27.8M2.81B1%
EBITDA-3.73M-212.42M2%
Gain YTD-24.936-37.94766%
P/E RatioN/AN/A-
Revenue10.9K0-
Total Cash15K808M0%
Total Debt244K878K28%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
40%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
38%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 27 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UIPMX42.460.27
+0.64%
Victory Precious Metals & Minerals Instl
HNCSX21.93N/A
N/A
Hartford International Growth R4
RGBFX41.05-0.02
-0.05%
American Funds Global Balanced R5
JSCRX19.72-0.03
-0.15%
PGIM Jennison Small Company R
TSLTX5.24-0.01
-0.19%
Transamerica Small Cap Value I3

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
33%
Loosely correlated
N/A
VANI - GLABF
29%
Poorly correlated
-3.23%
WHWK - GLABF
23%
Poorly correlated
+1.05%
VKTX - GLABF
20%
Poorly correlated
-4.88%
ENTO - GLABF
8%
Poorly correlated
+2.00%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-4.88%
NEVPF - VKTX
45%
Loosely correlated
N/A
LRMR - VKTX
42%
Loosely correlated
-0.89%
SYRE - VKTX
41%
Loosely correlated
+4.77%
GPCR - VKTX
40%
Loosely correlated
-1.80%
RGNX - VKTX
39%
Loosely correlated
-1.43%
More